Skip to main content
Clinical Trials/IRCT20210415050976N9
IRCT20210415050976N9
Recruiting
Phase 3

The effect of remifentanil on hemodynamic changes and laxity of patients undergoing complete abdominal hysterectomy

Jahrom University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Jahrom University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Jahrom University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patient consent to study
  • Anesthesia class one and two
  • Age 20 to 60 years

Exclusion Criteria

  • Existence of cervical malignancy
  • History of diabetes or endometriosis
  • History of neurological diseases
  • Abnormal Pap smear
  • Chronic pelvic pain
  • History of heart disease or hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials